Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

SAE Rate Higher With Nilotinib Versus Placebo in Parkinson Disease

drugsDecember 18, 2019

Tag: SAE , nilotinib , placebo , Parkinson

PharmaSources Customer Service